Kosaki N, Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Yoshida H, Ogata M, Tazaki H
Juntendo University, Urayasu Hospital.
Jpn J Antibiot. 1989 Oct;42(10):2189-312.
Changes in the susceptibility of various infectious microorganisms to antimicrobial agents from 1982 to 1986 were evaluated. The microorganisms investigated were Escherichia coli, Klebsiella spp., Citrobacter spp., Enterobacter spp., Proteus spp., Serratia marcescens and Pseudomonas aeruginosa isolated from patients with urinary tract infections. We compared susceptibilities of microorganisms obtained from simple urinary tract infections with those from complicated infections with or without indwelling catheter. Among penicillins, mecillinam (MPC) showed the strongest activity against E. coli obtained from the patients: 3.13 to 6.25 micrograms/ml of MPC inhibited the growth of over 90% of the isolates. Among the second and the third generation cephalosporins, cefotiam and cefmenoxime (CMX) showed the strongest activity and the growth of isolates was inhibited at concentrations of 0.39 to 0.78 microgram/ml and below 0.10 to 0.20 microgram/ml, respectively. The activities of penicillins against Klebsiella spp. were weak. CMX showed strong activity against Klebsiella spp; 91.7% of the isolates from patients with simple infections were inhibited at 0.39 microgram/ml of the agent; 90.7% and 91.6% of isolates from patients with complicated infections with or without indwelling catheter were inhibited at 0.78 microgram/ml and 1.56 microgram/ml of the agent, respectively. Gentamicin (GM) also showed strong activity against isolates from patients with simple infections and weaker activity against isolates from patients with complicated infections with the catheter; 0.78 microgram/ml of ofloxacin (OFLX) inhibited the growths of 90% of the isolates from these patients. Penicillins showed weak activity against Citrobacter spp. obtained from the patients. Among the second and the third generation cephalosporins, CMX and latamoxef (LMOX) showed strong activities against the Citrobacter isolates; about 50% of the isolates were inhibited at 0.20 microgram/ml of either agent. 1.56 microgram/ml of minocycline inhibited the growth of 75 to 90% of the isolates and 1.56 microgram/ml of OFLX inhibited the growth of 93 to 100% of the isolates. Against isolates of Proteus spp. penicillins also showed weak activities. Among them, however, piperacillin (PIPC) inhibited the growth of over 90% of the isolates at concentrations ranging from 0.78 to 1.56 micrograms/ml. Among the second and third generation cephalosporins, CMX and LMOX showed strong activities; 0.20 microgram/ml of CMX inhibited the growth of 94.4%, 90.4%, and 83.1% of isolates from the 3 types of the patients, respectively. 0.20 microgram/ml of LMOX inhibited the growth of 94.4%, 91.8%, and 88.3% of the isolates, respectively. Enterobacter spp. showed resistance to the beta-lactam antibiotics.(ABSTRACT TRUNCATED AT 400 WORDS)
评估了1982年至1986年期间各种传染性微生物对抗菌药物敏感性的变化。所研究的微生物为从尿路感染患者中分离出的大肠杆菌、克雷伯菌属、柠檬酸杆菌属、肠杆菌属、变形杆菌属、粘质沙雷氏菌和铜绿假单胞菌。我们比较了单纯尿路感染患者分离出的微生物与有或无留置导管的复杂感染患者分离出的微生物的敏感性。在青霉素类中,美西林(MPC)对患者分离出的大肠杆菌显示出最强的活性:3.13至6.25微克/毫升的MPC可抑制90%以上分离株的生长。在第二代和第三代头孢菌素中,头孢替安和头孢甲肟(CMX)显示出最强的活性,分离株的生长分别在0.39至0.78微克/毫升和低于0.10至0.20微克/毫升的浓度下受到抑制。青霉素类对克雷伯菌属的活性较弱。CMX对克雷伯菌属显示出强活性;单纯感染患者分离株中91.7%在0.39微克/毫升的该药物浓度下受到抑制;有或无留置导管的复杂感染患者分离株中,分别有90.7%和91.6%在0.78微克/毫升和1.56微克/毫升的该药物浓度下受到抑制。庆大霉素(GM)对单纯感染患者的分离株也显示出强活性,对有导管的复杂感染患者的分离株活性较弱;0.78微克/毫升的氧氟沙星(OFLX)可抑制这些患者9